Exchange: OTC·Updated 12:29 PM EDT

OBIMF Ondine Biomedical Inc

$0.25
$0.00
(0.00%)
Today
Mkt Cap$129.59M
Vol200,000.00

About OBIMF

Ondine Biomedical, Inc. operates as a life sciences company that develops photodisinfection-based therapies to address drug-resistant infections. Its platform technology called antimicrobial photodynamic disinfection to help prevent and help treat infections across many therapeutic areas in healthcare and industry settings. The firm's novel, patented platform technology both reduces inflammation and eliminates harmful pathogens, rapidly destroying bacteria, fungi and viruses including superbugs and SARS-CoV-2. The company was founded by Carolyn Cross on September 9, 1996 and is headquartered in Vancouver, Canada.
50

Neutral Sentiment

How do you feel about OBIMF?

Advertisement|Remove ads.